SCHEMBL14928408

SCHEMBL14928408

CC[C@@H](C)Nc1nc(Cl)c(C#N)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.48
GLP1R P43220 2/20 0.39
PGK1 P00558 1/20 0.38
JAK3 P52333 4/20 0.35
JAK2 O60674 3/20 0.35
LIMK1 P53667 1/20 0.35
LIMK2 P53671 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CDK2 P24941 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
POLB P06746 1/20 0.34
CTSK P43235 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MUSK O15146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14909858 0.88 KHK (0.50) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14909860 0.88 KHK (0.50) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928731 0.86 KHK (0.46) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928398 0.86 KHK (0.46) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928701 0.86 KHK (0.46) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928428 0.85 KHK (0.44) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928541 0.84 KHK (0.47) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928623 0.84 KHK (0.43) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928858 0.84 KHK (0.43) KHKPGK1JAK3JAK2LIMK1
SCHEMBL14928564 0.83 KHK (0.50) KHKPGK1JAK3JAK2LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK KHK 2008/4885GLP1R 654/4885PGK1 4462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.